PTPRF_HUMAN - dbPTM
PTPRF_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PTPRF_HUMAN
UniProt AC P10586
Protein Name Receptor-type tyrosine-protein phosphatase F
Gene Name PTPRF
Organism Homo sapiens (Human).
Sequence Length 1907
Subcellular Localization Membrane
Single-pass type I membrane protein.
Protein Description Possible cell adhesion receptor. It possesses an intrinsic protein tyrosine phosphatase activity (PTPase) and dephosphorylates EPHA2 regulating its activity.; The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one..
Protein Sequence MAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEVIEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEEQLPPGFPSIDMGPQLKVVEKARTATMLCAAGGNPDPEISWFKDFLPVDPATSNGRIKQLRSGALQIESSEESDQGKYECVATNSAGTRYSAPANLYVRVRRVAPRFSIPPSSQEVMPGGSVNLTCVAVGAPMPYVKWMMGAEELTKEDEMPVGRNVLELSNVVRSANYTCVAISSLGMIEATAQVTVKALPKPPIDLVVTETTATSVTLTWDSGNSEPVTYYGIQYRAAGTEGPFQEVDGVATTRYSIGGLSPFSEYAFRVLAVNSIGRGPPSEAVRARTGEQAPSSPPRRVQARMLSASTMLVQWEPPEEPNGLVRGYRVYYTPDSRRPPNAWHKHNTDAGLLTTVGSLLPGITYSLRVLAFTAVGDGPPSPTIQVKTQQGVPAQPADFQAEVESDTRIQLSWLLPPQERIIMYELVYWAAEDEDQQHKVTFDPTSSYTLEDLKPDTLYRFQLAARSDMGVGVFTPTIEARTAQSTPSAPPQKVMCVSMGSTTVRVSWVPPPADSRNGVITQYSVAYEAVDGEDRGRHVVDGISREHSSWDLVGLEKWTEYRVWVRAHTDVGPGPESSPVLVRTDEDVPSGPPRKVEVEPLNSTAVHVYWKLPVPSKQHGQIRGYQVTYVRLENGEPRGLPIIQDVMLAEAQWRPEESEDYETTISGLTPETTYSVTVAAYTTKGDGARSKPKIVTTTGAVPGRPTMMISTTAMNTALLQWHPPKELPGELLGYRLQYCRADEARPNTIDFGKDDQHFTVTGLHKGTTYIFRLAAKNRAGLGEEFEKEIRTPEDLPSGFPQNLHVTGLTTSTTELAWDPPVLAERNGRIISYTVVFRDINSQQELQNITTDTRFTLTGLKPDTTYDIKVRAWTSKGSGPLSPSIQSRTMPVEQVFAKNFRVAAAMKTSVLLSWEVPDSYKSAVPFKILYNGQSVEVDGHSMRKLIADLQPNTEYSFVLMNRGSSAGGLQHLVSIRTAPDLLPHKPLPASAYIEDGRFDLSMPHVQDPSLVRWFYIVVVPIDRVGGSMLTPRWSTPEELELDELLEAIEQGGEEQRRRRRQAERLKPYVAAQLDVLPETFTLGDKKNYRGFYNRPLSPDLSYQCFVLASLKEPMDQKRYASSPYSDEIVVQVTPAQQQEEPEMLWVTGPVLAVILIILIVIAILLFKRKRTHSPSSKDEQSIGLKDSLLAHSSDPVEMRRLNYQTPGMRDHPPIPITDLADNIERLKANDGLKFSQEYESIDPGQQFTWENSNLEVNKPKNRYANVIAYDHSRVILTSIDGVPGSDYINANYIDGYRKQNAYIATQGPLPETMGDFWRMVWEQRTATVVMMTRLEEKSRVKCDQYWPARGTETCGLIQVTLLDTVELATYTVRTFALHKSGSSEKRELRQFQFMAWPDHGVPEYPTPILAFLRRVKACNPLDAGPMVVHCSAGVGRTGCFIVIDAMLERMKHEKTVDIYGHVTCMRSQRNYMVQTEDQYVFIHEALLEAATCGHTEVPARNLYAHIQKLGQVPPGESVTAMELEFKLLASSKAHTSRFISANLPCNKFKNRLVNIMPYELTRVCLQPIRGVEGSDYINASFLDGYRQQKAYIATQGPLAESTEDFWRMLWEHNSTIIVMLTKLREMGREKCHQYWPAERSARYQYFVVDPMAEYNMPQYILREFKVTDARDGQSRTIRQFQFTDWPEQGVPKTGEGFIDFIGQVHKTKEQFGQDGPITVHCSAGVGRTGVFITLSIVLERMRYEGVVDMFQTVKTLRTQRPAMVQTEDQYQLCYRAALEYLGSFDHYAT
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
117N-linked_GlycosylationTNSLGEINTSAKLSV
CCCCCCCCCCCCEEE
24.55UniProtKB CARBOHYD
144UbiquitinationIDMGPQLKVVEKART
CCCCCCEEHHHHHHH
38.7021906983
144 (in isoform 1)Ubiquitination-38.7021890473
144 (in isoform 2)Ubiquitination-38.7021890473
200O-linked_GlycosylationQIESSEESDQGKYEC
EEECCCCHHCCEEEE
31.05-
200O-linked_GlycosylationQIESSEESDQGKYEC
EEECCCCHHCCEEEE
31.059295285
205PhosphorylationEESDQGKYECVATNS
CCHHCCEEEEEEECC
22.7620068231
210PhosphorylationGKYECVATNSAGTRY
CEEEEEEECCCCCCE
14.8720068231
212PhosphorylationYECVATNSAGTRYSA
EEEEEECCCCCCEEC
24.5820068231
215PhosphorylationVATNSAGTRYSAPAN
EEECCCCCCEECCCE
26.5920068231
217PhosphorylationTNSAGTRYSAPANLY
ECCCCCCEECCCEEE
14.7130576142
218O-linked_GlycosylationNSAGTRYSAPANLYV
CCCCCCEECCCEEEE
25.20OGP
218PhosphorylationNSAGTRYSAPANLYV
CCCCCCEECCCEEEE
25.2030576142
224PhosphorylationYSAPANLYVRVRRVA
EECCCEEEEEEEEEC
5.9930576142
248PhosphorylationQEVMPGGSVNLTCVA
CCCCCCCCEEEEEEE
17.4723879269
250N-linked_GlycosylationVMPGGSVNLTCVAVG
CCCCCCEEEEEEEEC
31.18UniProtKB CARBOHYD
262PhosphorylationAVGAPMPYVKWMMGA
EECCCCCHHHHHHCC
14.3823879269
274UbiquitinationMGAEELTKEDEMPVG
HCCHHCCCCCCCCCC
75.6521906983
274 (in isoform 1)Ubiquitination-75.6521890473
274 (in isoform 2)Ubiquitination-75.6521890473
295N-linked_GlycosylationSNVVRSANYTCVAIS
HHHHHHCCCEEEEEE
33.61UniProtKB CARBOHYD
296PhosphorylationNVVRSANYTCVAISS
HHHHHCCCEEEEEEC
10.96-
348O-linked_GlycosylationSGNSEPVTYYGIQYR
CCCCCCEEEEEEEEE
23.03OGP
359O-linked_GlycosylationIQYRAAGTEGPFQEV
EEEEECCCCCCCCEE
32.80OGP
359PhosphorylationIQYRAAGTEGPFQEV
EEEEECCCCCCCCEE
32.8021406692
371PhosphorylationQEVDGVATTRYSIGG
CEECCEEEEEEECCC
14.9221406692
372PhosphorylationEVDGVATTRYSIGGL
EECCEEEEEEECCCC
20.1921406692
380PhosphorylationRYSIGGLSPFSEYAF
EEECCCCCCHHHHHH
27.46-
394PhosphorylationFRVLAVNSIGRGPPS
HHHHHHHCCCCCCCH
21.5921406692
447PhosphorylationPNGLVRGYRVYYTPD
CCCEECEEEEEECCC
6.0724043423
450PhosphorylationLVRGYRVYYTPDSRR
EECEEEEEECCCCCC
7.8224043423
451PhosphorylationVRGYRVYYTPDSRRP
ECEEEEEECCCCCCC
14.6724043423
452PhosphorylationRGYRVYYTPDSRRPP
CEEEEEECCCCCCCC
11.7024043423
455PhosphorylationRVYYTPDSRRPPNAW
EEEECCCCCCCCCCC
31.2424043423
485PhosphorylationLLPGITYSLRVLAFT
HCCCCCEEEEEEEEE
10.8924719451
507O-linked_GlycosylationSPTIQVKTQQGVPAQ
CCEEEEEECCCCCCC
27.54OGP
568O-linked_GlycosylationFDPTSSYTLEDLKPD
ECCCCCCCHHHCCCC
26.14OGP
594PhosphorylationDMGVGVFTPTIEART
CCCCCEECCCEEEEC
19.67-
596PhosphorylationGVGVFTPTIEARTAQ
CCCEECCCEEEECCC
28.52-
601PhosphorylationTPTIEARTAQSTPSA
CCCEEEECCCCCCCC
35.7823090842
604PhosphorylationIEARTAQSTPSAPPQ
EEEECCCCCCCCCCC
39.5623090842
605PhosphorylationEARTAQSTPSAPPQK
EEECCCCCCCCCCCE
14.8023090842
607PhosphorylationRTAQSTPSAPPQKVM
ECCCCCCCCCCCEEE
54.2023090842
617PhosphorylationPQKVMCVSMGSTTVR
CCEEEEEECCCCEEE
16.7023090842
620PhosphorylationVMCVSMGSTTVRVSW
EEEEECCCCEEEEEE
16.5623090842
621PhosphorylationMCVSMGSTTVRVSWV
EEEECCCCEEEEEEC
24.4723090842
622PhosphorylationCVSMGSTTVRVSWVP
EEECCCCEEEEEECC
14.1723090842
688PhosphorylationRVWVRAHTDVGPGPE
EEEEEECCCCCCCCC
31.2522210691
697PhosphorylationVGPGPESSPVLVRTD
CCCCCCCCCEEEECC
19.8422210691
703PhosphorylationSSPVLVRTDEDVPSG
CCCEEEECCCCCCCC
35.94-
709PhosphorylationRTDEDVPSGPPRKVE
ECCCCCCCCCCCEEE
64.87-
721N-linked_GlycosylationKVEVEPLNSTAVHVY
EEEEEECCCCEEEEE
48.29UniProtKB CARBOHYD
777PhosphorylationAQWRPEESEDYETTI
CCCCCCCCCCCEEEC
33.8230576142
788PhosphorylationETTISGLTPETTYSV
EEECCCCCCCCEEEE
23.7030576142
794PhosphorylationLTPETTYSVTVAAYT
CCCCCEEEEEEEEEE
14.8230576142
816PhosphorylationSKPKIVTTTGAVPGR
CCCEEEEECCCCCCC
16.61-
817PhosphorylationKPKIVTTTGAVPGRP
CCEEEEECCCCCCCC
17.49-
825PhosphorylationGAVPGRPTMMISTTA
CCCCCCCEEEEEECC
20.29-
830O-linked_GlycosylationRPTMMISTTAMNTAL
CCEEEEEECCHHHHH
13.98OGP
959N-linked_GlycosylationTVVFRDINSQQELQN
EEEEECCCCHHHHCC
37.7519349973
959N-linked_GlycosylationTVVFRDINSQQELQN
EEEEECCCCHHHHCC
37.7519349973
966N-linked_GlycosylationNSQQELQNITTDTRF
CCHHHHCCCCCCCCE
46.31UniProtKB CARBOHYD
966N-linked_GlycosylationNSQQELQNITTDTRF
CCHHHHCCCCCCCCE
46.3116335952
968PhosphorylationQQELQNITTDTRFTL
HHHHCCCCCCCCEEE
26.6026074081
969PhosphorylationQELQNITTDTRFTLT
HHHCCCCCCCCEEEC
31.4126074081
971PhosphorylationLQNITTDTRFTLTGL
HCCCCCCCCEEECCC
26.1226074081
974PhosphorylationITTDTRFTLTGLKPD
CCCCCCEEECCCCCC
21.8126074081
976PhosphorylationTDTRFTLTGLKPDTT
CCCCEEECCCCCCCE
37.0926074081
996PhosphorylationRAWTSKGSGPLSPSI
EEEECCCCCCCCCCH
40.7624719451
1000PhosphorylationSKGSGPLSPSIQSRT
CCCCCCCCCCHHCCC
21.53-
1007O-linked_GlycosylationSPSIQSRTMPVEQVF
CCCHHCCCCCHHHHH
30.95OGP
1025AcetylationFRVAAAMKTSVLLSW
HHHHHHHCEEEEEEE
32.6819820855
1026PhosphorylationRVAAAMKTSVLLSWE
HHHHHHCEEEEEEEE
15.81-
1027PhosphorylationVAAAMKTSVLLSWEV
HHHHHCEEEEEEEEC
12.78-
1031PhosphorylationMKTSVLLSWEVPDSY
HCEEEEEEEECCCCC
19.61-
1045AcetylationYKSAVPFKILYNGQS
CCCCCCEEEEECCEE
26.2319820861
1092PhosphorylationGGLQHLVSIRTAPDL
CCHHHHEEEEECCCC
16.8324719451
1108PhosphorylationPHKPLPASAYIEDGR
CCCCCCCCEEEECCC
21.4730257219
1110PhosphorylationKPLPASAYIEDGRFD
CCCCCCEEEECCCEE
11.4430257219
1286 (in isoform 2)Ubiquitination-26.7621890473
1289PhosphorylationLLFKRKRTHSPSSKD
HHHHHCCCCCCCCCC
29.7320873877
1291PhosphorylationFKRKRTHSPSSKDEQ
HHHCCCCCCCCCCHH
26.3420873877
1293PhosphorylationRKRTHSPSSKDEQSI
HCCCCCCCCCCHHCC
53.7020873877
1294PhosphorylationKRTHSPSSKDEQSIG
CCCCCCCCCCHHCCC
47.7325849741
1294 (in isoform 2)Ubiquitination-47.7321890473
1295UbiquitinationRTHSPSSKDEQSIGL
CCCCCCCCCHHCCCC
70.4021906983
1295 (in isoform 1)Ubiquitination-70.4021890473
1299PhosphorylationPSSKDEQSIGLKDSL
CCCCCHHCCCCCHHH
19.3130266825
1303UbiquitinationDEQSIGLKDSLLAHS
CHHCCCCCHHHHHCC
39.8121906983
1303 (in isoform 1)Ubiquitination-39.8121890473
1305PhosphorylationQSIGLKDSLLAHSSD
HCCCCCHHHHHCCCC
24.5630266825
1310PhosphorylationKDSLLAHSSDPVEMR
CHHHHHCCCCHHHHH
30.7225849741
1311PhosphorylationDSLLAHSSDPVEMRR
HHHHHCCCCHHHHHH
35.7525849741
1321PhosphorylationVEMRRLNYQTPGMRD
HHHHHCCCCCCCCCC
20.5321945579
1323PhosphorylationMRRLNYQTPGMRDHP
HHHCCCCCCCCCCCC
16.0821945579
1335PhosphorylationDHPPIPITDLADNIE
CCCCCCHHHHHHHHH
21.4324719451
13452-HydroxyisobutyrylationADNIERLKANDGLKF
HHHHHHHHHCCCCCC
51.90-
1345UbiquitinationADNIERLKANDGLKF
HHHHHHHHHCCCCCC
51.90-
1351UbiquitinationLKANDGLKFSQEYES
HHHCCCCCCCCCCCC
48.80-
1356PhosphorylationGLKFSQEYESIDPGQ
CCCCCCCCCCCCCCC
13.82-
1367 (in isoform 2)Ubiquitination-12.2221890473
1376UbiquitinationNSNLEVNKPKNRYAN
CCCCEECCCCCCEEE
63.6521906983
1376 (in isoform 1)Ubiquitination-63.6521890473
1381PhosphorylationVNKPKNRYANVIAYD
ECCCCCCEEEEEEEC
16.3621945579
1387PhosphorylationRYANVIAYDHSRVIL
CEEEEEEECCCEEEE
11.7628796482
1390PhosphorylationNVIAYDHSRVILTSI
EEEEECCCEEEEEEC
25.9128796482
1403PhosphorylationSIDGVPGSDYINANY
ECCCCCCCCCCCCEE
22.5927642862
1405PhosphorylationDGVPGSDYINANYID
CCCCCCCCCCCEECC
9.5827642862
1410PhosphorylationSDYINANYIDGYRKQ
CCCCCCEECCCCCCC
9.66-
1459MalonylationLEEKSRVKCDQYWPA
CHHHHCCCCCCCCCC
30.8626320211
1572UbiquitinationLERMKHEKTVDIYGH
HHHHCCCCCEEEEEE
54.27-
1573PhosphorylationERMKHEKTVDIYGHV
HHHCCCCCEEEEEEE
22.04-
1577PhosphorylationHEKTVDIYGHVTCMR
CCCCEEEEEEEEECC
9.1927642862
1621PhosphorylationEVPARNLYAHIQKLG
CCCHHHHHHHHHHHC
10.3221945579
16502-HydroxyisobutyrylationFKLLASSKAHTSRFI
EHHHHCCCCCHHHHH
41.51-
1650UbiquitinationFKLLASSKAHTSRFI
EHHHHCCCCCHHHHH
41.51-
1665UbiquitinationSANLPCNKFKNRLVN
HCCCCHHHHCCCCHH
65.51-
1676PhosphorylationRLVNIMPYELTRVCL
CCHHCCCHHHHHHHC
13.2421945579
1679PhosphorylationNIMPYELTRVCLQPI
HCCCHHHHHHHCCCC
14.7621945579
1692PhosphorylationPIRGVEGSDYINASF
CCCCCCCCCCCCHHH
17.4621945579
1694PhosphorylationRGVEGSDYINASFLD
CCCCCCCCCCHHHCC
9.5821945579
1698PhosphorylationGSDYINASFLDGYRQ
CCCCCCHHHCCCHHH
23.1227642862
1703PhosphorylationNASFLDGYRQQKAYI
CHHHCCCHHHCCEEE
12.6227642862
1707UbiquitinationLDGYRQQKAYIATQG
CCCHHHCCEEEEECC
34.51-
1709PhosphorylationGYRQQKAYIATQGPL
CHHHCCEEEEECCCC
9.7227642862
1748MalonylationLREMGREKCHQYWPA
HHHHCHHHHHHHCCC
35.3426320211
1752PhosphorylationGREKCHQYWPAERSA
CHHHHHHHCCCCHHC
6.95-
1777PhosphorylationAEYNMPQYILREFKV
HHCCCCHHHHHEEEE
8.96-
1783UbiquitinationQYILREFKVTDARDG
HHHHHEEEEECCCCC
39.20-
1785PhosphorylationILREFKVTDARDGQS
HHHEEEEECCCCCCC
25.24-
1792PhosphorylationTDARDGQSRTIRQFQ
ECCCCCCCEEEEEEE
36.60-
1801 (in isoform 2)Ubiquitination-26.7721890473
1810UbiquitinationWPEQGVPKTGEGFID
CCCCCCCCCCCCHHH
67.752190698
1810 (in isoform 1)Ubiquitination-67.7521890473
1824UbiquitinationDFIGQVHKTKEQFGQ
HHHHCEEECHHHHCC
63.54-
1861PhosphorylationIVLERMRYEGVVDMF
HHHHHHCCCCHHHHH
14.0012496362
1870PhosphorylationGVVDMFQTVKTLRTQ
CHHHHHHHHHHHHCC
16.8328509920
1888PhosphorylationMVQTEDQYQLCYRAA
CCCCHHHHHHHHHHH
18.7721945579
1892PhosphorylationEDQYQLCYRAALEYL
HHHHHHHHHHHHHHH
16.3321945579
1898PhosphorylationCYRAALEYLGSFDHY
HHHHHHHHHCCCCCC
19.74-
1901PhosphorylationAALEYLGSFDHYAT-
HHHHHHCCCCCCCC-
25.5528176443
1905PhosphorylationYLGSFDHYAT-----
HHCCCCCCCC-----
17.4928796482
1907PhosphorylationGSFDHYAT-------
CCCCCCCC-------
31.7928796482

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseMARCHF9Q86YJ5
PMID:19457934

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PTPRF_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PTPRF_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CTNB1_HUMANCTNNB1physical
11245482
LIPA1_HUMANPPFIA1physical
8524829
LIPA1_HUMANPPFIA1physical
7796809
RET_HUMANRETphysical
11121408
TRIO_HUMANTRIOphysical
8643598
CAV1_HUMANCAV1physical
12176037
CTNB1_HUMANCTNNB1physical
9245795
PLAK_HUMANJUPphysical
9245795
LIPA1_HUMANPPFIA1physical
9624153
LIPA3_HUMANPPFIA3physical
9624153
LIPA2_HUMANPPFIA2physical
9624153
ARBK1_HUMANADRBK1physical
26344197
DAAF5_HUMANDNAAF5physical
26344197
NAA50_HUMANNAA50physical
26344197
NPL4_HUMANNPLOC4physical
26344197
PFKAM_HUMANPFKMphysical
26344197
PICAL_HUMANPICALMphysical
26344197
PPWD1_HUMANPPWD1physical
26344197
SPS1_HUMANSEPHS1physical
26344197
FCL_HUMANTSTA3physical
26344197
UFD1_HUMANUFD1Lphysical
26344197
NUDC3_HUMANNUDCD3physical
27880917
NAA50_HUMANNAA50physical
27880917
TTI1_HUMANTTI1physical
27880917
F1712_HUMANFAM171A2physical
27880917
TRIO_HUMANTRIOphysical
27880917
SGT1_HUMANSUGT1physical
27880917
LIPA1_HUMANPPFIA1physical
27880917

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
616001Aplasia or hypoplasia of the breasts and/or nipples 2 (BNAH2)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PTPRF_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.";
Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.;
Nat. Biotechnol. 27:378-386(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-959 AND ASN-966, AND MASSSPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-966, AND MASSSPECTROMETRY.

TOP